BRCA1 and cancer: Interestingly, patients with BRCA1/2 biallelic alterations exhibited higher HRD scores than others with oHRR biallelic alterations (P<0.001), highlighting the greater impact of BRCA1/2 on HRD in BRCA-associated cancers.